8:55am ET
Health and Healthcare
Big Pharma Short Sellers Get Selective
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Companies
/Healthcare
Bristol-Myers Squibb Company
$66.58
▼ $0.37 (−0.55%) today
Markets closed · 10:31am ET
BMY Coverage
Page 14
9:55am ET
Health and Healthcare
Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020
Independent research firm Argus sees better than 25% potential upside for Bristol-Myers Squibb in the coming year.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
9:45am ET
Health and Healthcare
Big Pharma Short Sellers Grow More Selective
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
9:00am ET
Health and Healthcare
Big Pharma Short Sellers Hike Their Bets
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
12:34pm ET
Health and Healthcare
Starboard Value Stake Momentarily Shakes Up CVS
A report that activist investor firm Starboard Value had taken a stake in CVS momentarily lifted the drugstore and health insurer's share price.
8:50am ET
Health and Healthcare
Big Pharma Scares Off Short Sellers
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
9:59am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
9:40am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
11:20am ET
Investing
7 Giant Mergers Transforming the Face of Corporate America
Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and investors alike are having to view corporate America.
8:35am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
3:20pm ET
Health and Healthcare
Is Amgen Overpaying for Celgene’s Psoriasis Treatment?
Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation to Celgene’s merger with Bristol-Myers Squibb.
12:10pm ET
Health and Healthcare
Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.